Pharmacokinetic study of lenvatinib suspension by a simple suspension method in thyroid cancer patients
Not Applicable
Recruiting
- Conditions
- Thyroid cancer
- Registration Number
- JPRN-UMIN000034349
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients known to be positive for human immunodeficiency virus 2) Patients determined difficult to be included in this study based on investigator's judgement 3) Women who are pregnant,possibily pregnant, or breastfeeding 4) Patients with serious psychiatric condition
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method